📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Safety and impact of eculizumab withdrawal in patients with atypical haemolytic uraemic syndrome: protocol for a multicentre, open-label, prospective, single-arm study. (2022)

First Author: Dunn S
Attributed to:  Personalised management of atypical haemolytic uraemic syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-054536

PubMed Identifier: 36123058

Publication URI: http://europepmc.org/abstract/MED/36123058

Type: Journal Article/Review

Volume: 12

Parent Publication: BMJ open

Issue: 9

ISSN: 2044-6055